ABSTRACT
Jean-Martin Charcot is considered the father of modern neurology; alongside his work as a physician, professor, and researcher in this area, he was also artistically gifted with a taste for caricature. This historical note summarizes 8 caricatures by Charcot that exhibit a mixture of humor, satire, irony, and sarcasm.
Subject(s)
Neurology , Physicians , France , History, 19th Century , HumansSubject(s)
Antineoplastic Agents/adverse effects , Blepharospasm/drug therapy , Botulinum Toxins/therapeutic use , Edema/drug therapy , Imatinib Mesylate/adverse effects , Orbital Diseases/drug therapy , Aged , Blepharospasm/chemically induced , Edema/chemically induced , Humans , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/complications , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Male , Orbital Diseases/chemically induced , Treatment OutcomeABSTRACT
Jean-Martin Charcot, the most celebrated neurologist of the 19th century, had a profound influence on Sigmund Freud's career. Freud spent the winter of 1885-1886 working in Charcot's neurology department in Paris. During this period, he went to Charcot's house on several occasions to participate in the very famous Tuesday soirées under the guidance of Gilles de la Tourette. Freud was always very proud to be invited and curious to meet the Parisian intellectual elite. On these occasions, however, he was very apprehensive and made frequent use of cocaine. Due to anxiety and the need to appear creative in front of Charcot, it is possible that Freud used cocaine at other times.
Subject(s)
Cocaine-Related Disorders/history , Neurology/history , Anxiety/psychology , Cocaine-Related Disorders/psychology , Courage , History, 19th Century , History, 20th Century , ParisABSTRACT
ABSTRACT Jean-Martin Charcot, the most celebrated neurologist of the 19th century, had a profound influence on Sigmund Freud's career. Freud spent the winter of 1885-1886 working in Charcot's neurology department in Paris. During this period, he went to Charcot's house on several occasions to participate in the very famous Tuesday soirées under the guidance of Gilles de la Tourette. Freud was always very proud to be invited and curious to meet the Parisian intellectual elite. On these occasions, however, he was very apprehensive and made frequent use of cocaine. Due to anxiety and the need to appear creative in front of Charcot, it is possible that Freud used cocaine at other times.
RESUMO Jean-Martin Charcot, o neurologista mais célebre do século XIX, teve uma influência profunda na carreira de Sigmund Freud. Freud visitou o Departamento de Neurologia do Hospital Salpêtrière, em Paris, chefiado pelo professor Charcot, durante o inverno de 1885-1886. Durante este período, ele foi várias vezes à casa de Charcot para participar dos famosos saraus de terça-feira, sob a orientação de GiUes de la Tourette. Nessas ocasiões, Freud ficava sempre muito orgulhoso pelo convite, curioso por encontrar a elite intelectual Parisiense, mas também muito apreensivo, e fazia uso frequente de cocaína. Devido à ansiedade e à necessidade de aparentar-se produtivo diante de Charcot, é possível que Freud tenha usado cocaína outras vezes.
Subject(s)
History, 19th Century , History, 20th Century , Cocaine-Related Disorders/history , Neurology/history , Anxiety/psychology , Paris , Cocaine-Related Disorders/psychology , CourageABSTRACT
The authors describe the construction of a statue in honor of Professor Charcot, the father of modern neurology, in Paris in 1898, 5 years after his death. The Nazi invaders destroyed the statue, which was erected near the entrance to the Salpêtrière hospital with the support of his disciples and the international neurological community, in 1942 during World War II. An international campaign is now needed to rebuild the statue of this great neurologist.
Subject(s)
National Socialism/history , Neurologists/history , Neurology/history , World War II , France , History, 20th Century , HumansABSTRACT
Background - Jean-Martin Charcot had a profound influence on Sigmund Freud's life and career. The founders of Brazilian neurology and psychiatry were influenced by the ideas of Charcot and Freud. Objective - To describe Charcot's influence on Freud, and both on the beginning of Brazilian Neurology and Psychiatry. Results - After Freud's stay in Charcot's neurology service during the winter of 1885-1886, there was a shift in his interest from general neurology to hysteria, hypnosis and other psychological issues, which greatly influenced the development of psychoanalytic theory. Like Charcot, Freud would become an admirer of the arts, literature, and culture. When Freud began his collection, in the late 1890s, Charcot served as an important model. In Salpêtrière Hospital, Charcot was staging a show different from modernity, capable of inspiring Freud. Antonio Austregesilo founded the first Brazilian school of Neurology, in Rio de Janeiro, inspired in Charcot. Austresegilo also practiced psychiatry, and, together Juliano Moreira and others, is considered propagator of Freud's ideas in Brazil. Conclusion - The ideas of Charcot and Freud were fundamental in the formation of physicians who helped to found and to consolidate the Brazilian neurology and psychiatry.(AU)
Introdução - Jean-Martin Charcot exerceu uma profunda influência na vida e na carreira de Sigmund Freud. Os fundadores da neurologia e da psiquiatria brasileiras foram influenciados pelas ideias de Charcot e de Freud. Objetivo - Descrever a influência de Charcot sobre Freud e de ambos sobre o início da Neurologia e da Psiquiatria brasileiras. Resultados - Após a permanência de Freud no serviço de neurologia de Charcot durante o inverno de 1885-1886, houve uma mudança em seu interesse da neurologia geral para histeria, hipnose e outras questões psicológicas, o que influenciou muito o desenvolvimento da teoria psicanalítica. Como Charcot, Freud se tornaria admirador das artes, literatura e cultura. Quando Freud começou sua coleção, no final da década de 1890, Charcot serviu de modelo importante. No Hospital Salpêtrière, Charcot era a representação da modernidade, capaz de inspirar Freud. Antonio Austregésilo fundou a primeira escola brasileira de Neurologia, no Rio de Janeiro, inspirada em Charcot. Austresegilo também praticou psiquiatria, e, juntamente com Juliano Moreira e outros, é considerado propagador das ideias de Freud no Brasil.Conclusão - As ideias de Charcot e Freud foram fundamentais na formação de médicos que ajudaram a fundar e consolidar a neurologia e a psiquiatria brasileiras.(AU)
Subject(s)
Humans , History, 19th Century , History, 20th Century , Psychiatry/history , Psychoanalysis/history , Psychoanalytic Theory , Hysteria/psychology , Neurology/history , Biographies as Topic , Brazil , Education, Medical , HypnosisABSTRACT
Motor and non-motor manifestations are common and disabling features of hereditary spastic paraplegia (HSP). Botulinum toxin type A (Btx-A) is considered effective for spasticity and may improve gait in these patients. Little is known about the effects of Btx-A on non-motor symptoms in HSP patients. Objective To assess the efficacy of Btx-A on motor and non-motor manifestations in HSP patients. Methods Thirty-three adult patients with a clinical and molecular diagnosis of HSP were evaluated before and after Btx-A injections. Results Mean age was 41.7 ± 13.6 years and there were 18 women. Most patients had a pure phenotype and SPG4 was the most frequent genotype. The Btx-A injections resulted in a decrease in spasticity at the adductor muscles, and no other motor measure was significantly modified. In contrast, fatigue scores were significantly reduced after Btx-A injections. Conclusion Btx-A injections resulted in no significant functional motor improvement for HSP, but fatigue improved after treatment.
Subject(s)
Botulinum Toxins, Type A/therapeutic use , Motor Disorders/drug therapy , Motor Disorders/physiopathology , Neuromuscular Agents/therapeutic use , Spastic Paraplegia, Hereditary/drug therapy , Spastic Paraplegia, Hereditary/physiopathology , Adult , Age of Onset , Female , Gait/drug effects , Gait/physiology , Humans , Injections, Intramuscular , Male , Middle Aged , Muscle Fatigue/drug effects , Muscle Fatigue/physiology , Muscle Spasticity/drug therapy , Muscle Spasticity/physiopathology , Reproducibility of Results , Treatment OutcomeABSTRACT
INTRODUCTION: The spectrum of neurologic disorders associated with HIV infection is very broad, resulting from direct virus invasion, opportunistic infections, malignancies and toxic effects of drugs. METHODS: Among a large cohort of ataxia patients (Nâ¯=â¯1050) evaluated between 2008 and 2017, we detected four patients with HIV-infection who developed a pure progressive cerebellar ataxia syndrome combined with cerebellar atrophy. RESULTS: Adverse drug effects, opportunistic infections and malignancies as well as immune-reconstitution syndrome were ruled out based on history and laboratory data. The exact pathophysiological mechanisms of ataxia in HIV patients is not very clear, but seems to be immune-mediated or a direct neurotoxic virus effect leading to apoptosis of Purkinje and granular cells. CONCLUSION: HIV infection should be investigated in adult patients with undetermined sporadic progressive pure ataxia with cerebellar atrophy.
Subject(s)
Cerebellar Ataxia/etiology , Cerebellum/pathology , HIV Infections/complications , Spinocerebellar Degenerations/etiology , Adult , Atrophy/pathology , Cerebellar Ataxia/diagnostic imaging , Cerebellar Ataxia/physiopathology , Cerebellum/diagnostic imaging , Cohort Studies , Disease Progression , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Spinocerebellar Degenerations/diagnostic imaging , Spinocerebellar Degenerations/physiopathologyABSTRACT
ABSTRACT Motor and non-motor manifestations are common and disabling features of hereditary spastic paraplegia (HSP). Botulinum toxin type A (Btx-A) is considered effective for spasticity and may improve gait in these patients. Little is known about the effects of Btx-A on non-motor symptoms in HSP patients. Objective To assess the efficacy of Btx-A on motor and non-motor manifestations in HSP patients. Methods Thirty-three adult patients with a clinical and molecular diagnosis of HSP were evaluated before and after Btx-A injections. Results Mean age was 41.7 ± 13.6 years and there were 18 women. Most patients had a pure phenotype and SPG4 was the most frequent genotype. The Btx-A injections resulted in a decrease in spasticity at the adductor muscles, and no other motor measure was significantly modified. In contrast, fatigue scores were significantly reduced after Btx-A injections. Conclusion Btx-A injections resulted in no significant functional motor improvement for HSP, but fatigue improved after treatment.
RESUMO Manifestações motoras e não motoras são comuns e incapacitantes nas paraparesias espásticas hereditárias (PEH). Toxina botulínica do tipo A (TB-A) é considerada eficaz no tratamento da espasticidade e pode melhorar a marcha nesses pacientes. Pouco se sabe sobre os efeitos da TB-A sobre sintomas não-motores. Objetivo avaliar a eficácia da TB-A sobre manifestações motoras e não-motoras nas PEH. Método trinta e três pacientes adultos com PEH foram avaliados antes e depois das aplicações de TB-A. Resultados A média de idade foi 41,7 ± 13,6 anos e havia 18 mulheres. A maioria dos pacientes portava a forma pura e o genótipo mais comum foi SPG4. Houve diminuição da espasticidade dos músculos adutores da coxa sem melhora da marcha. A pontuação da fadiga reduziu após as injeções. Conclusão As aplicações de TB-A não melhoraram a marcha nos pacientes mas a redução da fadiga foi significativa após o tratamento.
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Spastic Paraplegia, Hereditary/physiopathology , Spastic Paraplegia, Hereditary/drug therapy , Botulinum Toxins, Type A/therapeutic use , Motor Disorders/physiopathology , Motor Disorders/drug therapy , Neuromuscular Agents/therapeutic use , Reproducibility of Results , Treatment Outcome , Age of Onset , Muscle Fatigue/drug effects , Muscle Fatigue/physiology , Gait/drug effects , Gait/physiology , Injections, Intramuscular , Muscle Spasticity/drug therapyABSTRACT
The authors review the relationship between Jean-Martin Charcot, the most celebrate Professor of Neurology of the XIX century, and his son, Jean-Baptiste Charcot, former a physician and neurologist and after Professor Charcot's death, a worldwide famous maritime explorer, the "Commander Charcot."
Subject(s)
Fathers/history , Neurology/history , Physicians , Research/history , Art , France , History, 19th Century , History, 20th Century , HumansABSTRACT
Jean-Martin Charcot is considered the father of modern neurology and was the first neurologist to hold a professorship of international stature devoted to the study of the diseases of the nervous system. His biographers paint an image of an austere presence, reserved manner, shyness, economy of gestures and an impenetrable, impassive face. However, a wry and sarcastic side of Charcot can be demonstrated in several situations, and these examples help to clarify the intricacies of his personality and work style.
Subject(s)
Neurologists/history , Neurology/history , Personality , History, 19th Century , ParisABSTRACT
ABSTRACT Jean-Martin Charcot is considered the father of modern neurology and was the first neurologist to hold a professorship of international stature devoted to the study of the diseases of the nervous system. His biographers paint an image of an austere presence, reserved manner, shyness, economy of gestures and an impenetrable, impassive face. However, a wry and sarcastic side of Charcot can be demonstrated in several situations, and these examples help to clarify the intricacies of his personality and work style.
RESUMO Jean-Martin Charcot é considerado o pai da moderna neurologia e o primeiro professor de doenças do sistema nervoso em todo o mundo. Os seus biógrafos o descrevem com uma imagem austera, reservado, tímido, com uma economia de gestos e uma face impassiva e impenetrável. Entretanto o lado sarcástico e irônico de Charcot pode ser demonstrado em diversas situações, com exemplos que ajudam a clarificar a sua complexa personalidade e o seu estilo de trabalho.
Subject(s)
History, 19th Century , Personality , Neurologists/history , Neurology/history , ParisABSTRACT
BACKGROUND AND PURPOSE: Ischemic stroke is one of the most frequent causes of death in Brazil. Many measures have been taken to reduce this tragic outcome, and one of those is the implementation of stroke units in hospitals. The aim of the present study is to analyze the in-hospital complications for patients with ischemic stroke admitted in a comprehensive stroke ward (CSW) as compared to patients admitted in a mixed rehabilitation ward (MRW). METHODS: A retrospective interventional study with historic controls of patients admitted to the Neurology Division between January 2010 and October 2013. Patients admitted between January 2010 and September 2012 were included in the MRW group, and patients admitted from October 2012 until October 2013 were included in the CSW group. Throughout the whole study period, the same team assisted all the patients. Both groups were paired in relation to age and gender. The rate of in-hospital complications, mortality, and independency on discharge were evaluated in both groups. RESULTS: Each group was comprised of 91 patients. There were no statistically significant differences for any of the risk factors analyzed between the 2 groups nor for outcome measures-in-hospital complications, mortality, and independence on discharge. CONCLUSION: The present study demonstrated that in-hospital complications, independence on discharge, and mortality have similar rates in patients admitted to an MRW compared to patients admitted to a CSW, when the same staff provided them with specialized in-hospital care. EVIDENCE LEVEL: Case-control study-Evidence Level 3.
ABSTRACT
Jean-Martin Charcot (1825-1893), recognized as the founder of Neurology and the first formal teacher of nervous system diseases, died on August 16, 1893, from acute pulmonary edema secondary to myocardial infarction. In his last years, there were several descriptions of his gait and posture disorders, suggesting the diagnosis of "lower-half parkinsonism" due to cerebrovascular disease.
Subject(s)
Parkinsonian Disorders/history , Vascular Diseases/history , Coronary Artery Disease/history , History, 19th Century , Neurology/historyABSTRACT
ABSTRACT Jean-Martin Charcot (1825-1893), recognized as the founder of Neurology and the first formal teacher of nervous system diseases, died on August 16, 1893, from acute pulmonary edema secondary to myocardial infarction. In his last years, there were several descriptions of his gait and posture disorders, suggesting the diagnosis of “lower-half parkinsonism” due to cerebrovascular disease.
RESUMO Jean-Martin Charcot (1825-1893) pode ser reconhecido como o fundador da Neurologia, bem como o primeiro professor de doenças do sistema nervoso. Ele morreu no dia 16 de Agosto de 1893, em decorrência de edema agudo de pulmão, secundário a infarto agudo do miocárdio. Nos últimos anos da vida de Charcot, ocorreram várias descrições de anormalidades da sua marcha e da sua postura, sugerindo o diagnóstico de parkinsonismo vascular.
Subject(s)
History, 19th Century , Vascular Diseases/history , Parkinsonian Disorders/history , Coronary Artery Disease/history , Neurology/historyABSTRACT
Three world-famous neurologists, Charcot and Mitchell, in the 19th century, and Lees, in this century, all of whom had great scientific curiosity, experimented with the psychoactive drugs hashish, mescal and yagé, respectively, in an attempt to increase their knowledge of neurological diseases and how the brain works.
Subject(s)
Neurology/history , Psychotropic Drugs/history , Cannabis , England , France , History, 19th Century , History, 20th Century , History, 21st Century , Humans , Mescaline/history , Mescaline/therapeutic use , Nervous System Diseases/drug therapy , Psychotropic Drugs/therapeutic use , United StatesABSTRACT
ABSTRACT Three world-famous neurologists, Charcot and Mitchell, in the 19th century, and Lees, in this century, all of whom had great scientific curiosity, experimented with the psychoactive drugs hashish, mescal and yagé, respectively, in an attempt to increase their knowledge of neurological diseases and how the brain works.
RESUMO Três mundialmente famosos neurologistas, Charcot e Mitchell, no século XIX, e Lees neste século, tiveram eles mesmos, experiências com drogas psico-ativas, com haxixe, mescalina e yagé, respectivamente, demonstrando a sua intensa curiosidade científica, na tentativa de aprimorar o seu conhecimento da função cerebral e das doenças neurológicas.
Subject(s)
Humans , History, 19th Century , History, 20th Century , History, 21st Century , Psychotropic Drugs/history , Neurology/history , Psychotropic Drugs/therapeutic use , United States , Cannabis , England , France , Mescaline/history , Mescaline/therapeutic use , Nervous System Diseases/drug therapyABSTRACT
The use of eponyms in neurology remains controversial, and important questions have been raised about their appropriateness. Different approaches have been taken, with some eponyms being excluded, others replaced, and new ones being created. An example is Hallervorden-Spatz syndrome, which has been replaced by neurodegeneration with brain iron accuulatium (NBIA). Amiothoplic lateral sclerosys (ALS), for which the eponym is Charcot's disease, has been replaced in the USA by Lou Gehrig's disease. Guillain-Barré syndrome (GBS) is an eponym that is still the subject of controversy, and various different names are associated with it. Finally,restless legs syndrome (RLS), which was for years known as Ekbom's syndrome, has been rechristened as RLS/Willis-Ekbom syndrome.
Subject(s)
Eponyms , Nervous System Diseases/history , Amyotrophic Lateral Sclerosis/history , Guillain-Barre Syndrome/history , History, 17th Century , History, 18th Century , History, 19th Century , History, 20th Century , History, 21st Century , Humans , Iron Metabolism Disorders/history , Neuroaxonal Dystrophies/history , Restless Legs Syndrome/historyABSTRACT
ABSTRACT The use of eponyms in neurology remains controversial, and important questions have been raised about their appropriateness. Different approaches have been taken, with some eponyms being excluded, others replaced, and new ones being created. An example is Hallervorden-Spatz syndrome, which has been replaced by neurodegeneration with brain iron accuulatium (NBIA). Amiothoplic lateral sclerosys (ALS), for which the eponym is Charcot’s disease, has been replaced in the USA by Lou Gehrig’s disease. Guillain-Barré syndrome (GBS) is an eponym that is still the subject of controversy, and various different names are associated with it. Finally,restless legs syndrome (RLS), which was for years known as Ekbom’s syndrome, has been rechristened as RLS/Willis-Ekbom syndrome.
RESUMO O uso de epônimos em neurologia permanece ainda controverso nos dias de hoje, e importantes questões tem sido levantadas sobre o seu uso. Diferentes abordagens têm sido feitas, com a exclusão de alguns epônimos, modificação ou criação de outros. Um exemplo é a síndrome de Hallervorden-Spatz (SHS), cuja denominação foi modificada para neurodegeneração associada com acúmulo de ferro cerebral (NBIA). Outro exemplo é a esclerose lateral amiotrófica (ELA), cujo epônimo doença de Charcot, tem sido substituído nos EUA por doença de Lou Gehring. A síndrome de Guillain-Barré (SGB) representa um epônimo em que a controvérsia persiste, e diferentes nomes têm sido associados ao clássico SGB. Por fim, a síndrome das pernas inquietas (SPI), que por anos foi definida como síndrome de Ekbom, e que na atualidade foi definida como SPI/síndrome de Willis-Ekbom.